PPARG and ADIPOQ gene polymorphisms increase type 2 diabetes mellitus risk in Asian Indian Sikhs: Pro12Ala still remains as the strongest predictor

Metabolism: Clinical and Experimental

Volumn 59, Issue 4, 2010, Pages 492-501

  Sanghera, Dharambir Kaur ^a   Demirci, Fatma Yesim ^b   Been, Latonya ^a   Ortega, Lyda ^a   Ralhan, Sarju ^c   Wander, Gurpreet Singh ^c   Mehra, Narinder Kumar ^d   Singh, Jairup ^e   Aston, Christopher Eric ^a   Mulvihill, John Joseph ^a   Kamboh, Ilyas Mohammad ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c Hero DMC Heart Institute   (India)

^d ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^e CENTRAL UNIVERSITY OF PUNJAB   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE;

ADIPOQ GENE; ADULT; AGED; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE; GENE LOCUS; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HIP; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PPARG GENE; PREDICTOR VARIABLE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; RISK;

EID: 77949478557     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.07.043     Document Type: Article

References (55)

1. Basnayat B., and Rajapaksa L.C. Cardiovascular and infectious diseases in South Asia: the double whammy. Br Med J 328 (2004) 781
2. Mather H.M., and Keen H. The Southhall Diabetes Survey: prevalence of known diabetes in Asians and Europeans. Br Med J (Clin Res Ed) 291 (1985) 1081-1084
3. McKeigue P.M., Pierpoint T., Ferrie J.E., and Marmot M.G. Relationship of glucose intolerance and hyperinsulinaemia to body fat pattern in south Asians and Europeans. Diabetologia 35 (1992) 785-791
4. McKeigue P.M., Miller G.J., and Marmot M.G. Coronary heart disease in south Asians overseas: a review. J Clin Epidemiol 42 (1989) 597-609
5. Kooner J.S., Baliga R.R., Wilding J., Crook D., Packard C.J., Banks L.M., et al. Abdominal obesity, impaired nonesterified fatty acid suppression, and insulin-mediated glucose disposal are early metabolic abnormalities in families with premature myocardial infarction. Arterioscler Thromb Vasc Biol 18 (1998) 1021-1026
6. Zimmet P.Z. Kelly West lecture 1991. Challenges in diabetes epidemiology-from west to the rest. Diabetes Care 15 (1992) 232-252
7. Parikh H., and Groop L. Candidate genes for type 2 diabetes. Rev Endocr Metab Disord 5 (2004) 151-176
8. Altshuler D., Hirschhorn J.N., Klannemark M., Lindgren C.M., Vohl M.C., Nemesh J., et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26 (2000) 76-80
9. Saxena R., Voight B.F., Lyssenko V., Burtt N.P., de Bakker P.I., Chen H., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science (New York, NY) 316 (2007) 1331-1336
10. Scott L.J., Mohlke K.L., Bonnycastle L.L., Willer C.J., Li Y., Duren W.L., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science (New York, NY) 316 (2007) 1341-1345
11. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-678
12. Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445 (2007) 881-885
13. Cauchi S., Nead K.T., Choquet H., Horber F., Potoczna N., Balkau B., et al. The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. BMC Med Genet 9 (2008) 45
14. Sanghera D.K., Ortega L., Han S., Singh J., Ralhan S.K., Wander G.S., et al. Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk. BMC Med Genet 9 (2008) 59
15. Zhu Y., Qi C., Korenberg J.R., Chen X.N., Noya D., Rao M.S., et al. Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms. Proc Natl Acad Sci USA 92 (1995) 7921-7925
16. Fajas L., Auboeuf D., Raspe E., Schoonjans K., Lefebvre A.M., Saladin R., et al. The organization, promoter analysis, and expression of the human PPARgamma gene. J Biol Chem 272 (1997) 18779-18789
17. Braissant O., Foufelle F., Scotto C., Dauca M., and Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137 (1996) 354-366
18. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., and Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 270 (1995) 12953-12956
19. Iwamoto Y., Kosaka K., Kuzuya T., Akanuma Y., Shigeta Y., and Kaneko T. Effects of troglitazone: a new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy. Diabetes Care 19 (1996) 151-156
20. Hara K., Boutin P., Mori Y., Tobe K., Dina C., Yasuda K., et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51 (2002) 536-540
21. Menzaghi C., Ercolino T., Di Paola R., Berg A.H., Warram J.H., Scherer P.E., et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 51 (2002) 2306-2312
22. Bouatia-Naji N., Meyre D., Lobbens S., Seron K., Fumeron F., Balkau B., et al. ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity. Diabetes 55 (2006) 545-550
23. Vionnet N., Hani E.H., Dupont S., Gallina S., Francke S., Dotte S., et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 67 (2000) 1470-1480
24. Lindsay R.S., Hanson R.L., Wiedrich C., Knowler W.C., Bennett P.H., and Baier L.J. The insulin gene variable number tandem repeat class I/III polymorphism is in linkage disequilibrium with birth weight but not type 2 diabetes in the Pima population. Diabetes 52 (2003) 187-193
25. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
26. Sanghera D.K., Bhatti J.S., Bhatti G.K., Ralhan S.K., Wander G.S., Singh J.R., et al. The Khatri Sikh Diabetes Study (SDS): study design, methodology, sample collection, and initial results. Hum Biol 78 (2006) 43-63
27. Sanghera D.K., Nath S.K., Ortega L., Gambarelli M., Kim-Howard X., Singh J.R., et al. TCF7L2 polymorphisms are associated with type 2 diabetes in Khatri Sikhs from North India: genetic variation affects lipid levels. Ann Hum Genet 72 (2008) 499-509
28. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 27 Suppl 1 (2004) S5-S10
29. Mogensen C.E., Neldam S., Tikkanen I., Oren S., Viskoper R., Watts R.W., et al. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. Br Med J 321 (2000) 1440-1444
30. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
31. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
32. Bamshad M., Kivisild T., Watkins W.S., Dixon M.E., Ricker C.E., Rao B.B., et al. Genetic evidence on the origins of Indian caste populations. Genome Res 11 (2001) 994-1004
33. Halldorsson B.V., Istrail S., and De La Vega F.M. Optimal selection of SNP markers for disease association studies. Hum Hered 58 (2004) 190-202
34. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (Oxford, England) 21 (2005) 263-265
35. Corton J.C., Anderson S.P., and Stauber A. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu Rev Pharmacol Toxicol 40 (2000) 491-518
36. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., et al. The nuclear receptor superfamily: the second decade. Cell 83 (1995) 835-839
37. Rangwala S.M., and Lazar M.A. Peroxisome proliferator-activated receptor gamma in diabetes and metabolism. Trends Pharmacol Sci 25 (2004) 331-336
38. De Vos P., Lefebvre A.M., Miller S.G., Guerre-Millo M., Wong K., Saladin R., et al. Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma. J Clin Invest 98 (1996) 1004-1009
39. Teboul L., Febbraio M., Gaillard D., Amri E.Z., Silverstein R., and Grimaldi P.A. Structural and functional characterization of the mouse fatty acid translocase promoter: activation during adipose differentiation. Biochem J 360 (2001) 305-312
40. Takata Y., Kitami Y., Yang Z.H., Nakamura M., Okura T., and Hiwada K. Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-delta and peroxisome proliferator-activated receptor-gamma. Circ Res 91 (2002) 427-433
41. Liu H.B., Hu Y.S., Medcalf R.L., Simpson R.W., and Dear A.E. Thiazolidinediones inhibit TNFalpha induction of PAI-1 independent of PPARgamma activation. Biochem Biophys Res Commun 334 (2005) 30-37
42. Kadowaki T., and Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 26 (2005) 439-451
43. Mousavinasab F., Tahtinen T., Jokelainen J., Koskela P., Vanhala M., Oikarinen J., et al. Effect of the Pro12Ala polymorphism of the PPARg2 gene on serum adiponectin changes. Endocrine 27 (2005) 307-309
44. Iwaki M., Matsuda M., Maeda N., Funahashi T., Matsuzawa Y., Makishima M., et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52 (2003) 1655-1663
45. Stumvoll M., Tschritter O., Fritsche A., Staiger H., Renn W., Weisser M., et al. Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 51 (2002) 37-41
46. Hu F.B., Doria A., Li T., Meigs J.B., Liu S., Memisoglu A., et al. Genetic variation at the adiponectin locus and risk of type 2 diabetes in women. Diabetes 53 (2004) 209-213
47. Vimaleswaran K.S., Radha V., Ramya K., Babu H.N., Savitha N., Roopa V., et al. A novel association of a polymorphism in the first intron of adiponectin gene with type 2 diabetes, obesity and hypoadiponectinemia in Asian Indians. Hum Genet 123 (2008) 599-605
48. Kotani K., Saiga K., Kurozawa Y., Sakane N., Tsuzaki K., and Hamada T. Adiponectin I164T gene polymorphism and the obesity-related effects on the Japanese female population. Clin Chim Acta 384 (2007) 182-183
49. McKeigue P.M., Shah B., and Marmot M.G. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337 (1991) 382-386
50. Chandalia M., Abate N., Garg A., Stray-Gundersen J., and Grundy S.M. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab 84 (1999) 2329-2335
51. Chambers J.C., Eda S., Bassett P., Karim Y., Thompson S.G., Gallimore J.R., et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation 104 (2001) 145-150
52. Radha V., Vimaleswaran K.S., Babu H.N., Abate N., Chandalia M., Satija P., et al. Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: evidence for heterogeneity. Diabetes Care 29 (2006) 1046-1051
53. Tai E.S., Corella D., Deurenberg-Yap M., Adiconis X., Chew S.K., Tan C.E., et al. Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population. J Lipid Res 45 (2004) 674-685
54. Papiha S.S. Genetic variation in India. Hum Biol 68 (1996) 607-628
55. Papiha S.S. The first 25 years of human genetics in Newcastle. Hum Biol 68 (1996) 603-606